Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
December 13, 2018	4	Statement of changes in beneficial ownership of securities	0000899243-18-030945.pdf 0000899243-18-030945.rtf View HTML
December 13, 2018	4	Statement of changes in beneficial ownership of securities	0000899243-18-030948.pdf 0000899243-18-030948.rtf View HTML
December 13, 2018	4	Statement of changes in beneficial ownership of securities	0000899243-18-030951.pdf 0000899243-18-030951.rtf View HTML
December 13, 2018	4	Statement of changes in beneficial ownership of securities	0000899243-18-030952.pdf 0000899243-18-030952.rtf View HTML
December 7, 2018	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000929638-18-000965.pdf 0000929638-18-000965.rtf 0000929638-18-000965.xls View HTML
November 30, 2018	425	Filing of certain prospectuses and communications in connection with business combination transactions	0001193125-18-338906.pdf 0001193125-18-338906.rtf 0001193125-18-338906.xls View HTML
November 29, 2018	425	Filing of certain prospectuses and communications in connection with business combination transactions	0001193125-18-337129.pdf 0001193125-18-337129.rtf 0001193125-18-337129.xls View HTML
November 16, 2018	425	Filing of certain prospectuses and communications in connection with business combination transactions	0001193125-18-328401.pdf 0001193125-18-328401.rtf 0001193125-18-328401.xls View HTML
November 16, 2018	425	Filing of certain prospectuses and communications in connection with business combination transactions	0001193125-18-328407.pdf 0001193125-18-328407.rtf View HTML
November 16, 2018	8-K	Report of unscheduled material events or corporate event	0001193125-18-328400.pdf 0001193125-18-328400.rtf 0001193125-18-328400.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax